ClinicalTrials.gg
Enrolling by invitationNCT07034170Updated Jul 20, 2026

Skeletal Muscle Mass on Prognosis and Recovery in Clinical Trial

An interventional study of Enhanced Rehabilitation Program in Out of Hospital Cardiac Arrest and Inhospital Cardiac Arrest, sponsored by National Taiwan University Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Non-randomized
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital — 6 open to participants now, 7 under way, none of them phase 3. Out-of-Hospital Cardiac Arrest · National Taiwan University Hospital.

Started
2025
the only one that year
No phase
8 of 15
2 open now
Registered
15th of 15
by date

Among the 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital, this one is the only one that started in 2025, is one of 8 with no phase, and was the 15th registered.

Out-of-Hospital Cardiac Arrest

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

Browse Out-of-Hospital Cardiac Arrest studies →

Open to participants now

6 of the 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Out-of-Hospital Cardiac Arrest by National Taiwan University Hospital, or all of them as a file.
02

Study summary

The objective of this research project is to develop an automated muscle mass measurement system based on computed tomography (CT) images using deep learning and artificial intelligence, and to construct a prognostic prediction model for patients who have experienced cardiac arrest and undergone resuscitation. The model will be validated using multicenter registry data and medical imaging. Furthermore, a clinical trial involving core muscle rehabilitation for post-resuscitation patients will be conducted to evaluate both short-term and long-term outcomes, aiming to comprehensively understand the impact of muscle mass on the prognosis of patients after cardiac arrest.

03

Conditions studied

  • Out of Hospital Cardiac Arrest
  • Inhospital Cardiac Arrest

Keywords

  • cardiac arrest
  • Skeletal muscle mass
  • rehabilitation
04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Non-traumatic adult patients who experienced sudden cardiac arrest
  • Achieved sustained return of spontaneous circulation (ROSC) for more than five minutes following successful resuscitation
  • Admitted to the ICU
  • Survived beyond 72 hours without successful weaning from mechanical ventilation

Exclusion criteria

Exclusion Criteria:

  • Age under 18 years
  • Pregnancy
  • Expected to be weaned from mechanical ventilation within 48 hours
  • Terminal-stage cancer or unwillingness to receive aggressive treatment
  • Unavailability of ICU care due to overcrowding in the emergency intensive care unit
  • Refusal to participate in the study by the patient or family members
  • Presence of an implanted pacemaker or defibrillator
  • Open wounds, severe edema, or deep vein thrombosis in the lower limbs
  • Pre-arrest status limited to wheelchair use or bedridden, unable to ambulate
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (estimated)

Study arms

  • No intervention
    control group
  • Experimental
    Intervention Group

    Participants in the arm group only performed joint-assisted movement.

    Behavioral: Enhanced Rehabilitation Program

Interventions

  • BehavioralEnhanced Rehabilitation Program

    Participants in the intervention group receive an enhanced rehabilitation program, including muscular electrical stimulation, guided active rehabilitation sessions, and structured physical engagement during periods of consciousness. The intervention is designed to promote functional improvement in post-cardiac arrest patients.

06

What researchers measure

Primary outcomes

  1. skeletal muscle mass

    Muscle changes were measured weekly using a handheld ultrasound.

    Time frame: 21 days

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for May 2028, 35 months after the start.

Of 93 non-industry interventional studies with no phase under Out-of-Hospital Cardiac Arrest, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 57. This study's planned 35 months is close to that.

Counting every sponsor, half of 95 studies reached it within 34 months; a quarter within 19 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 5, 2025
First posted
Jun 24, 2025
StartActual
Jun 1, 2025
Primary completionEst.
May 30, 2028
CompletionEst.
Dec 31, 2028
Last update
Jul 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07034170
Responsible party
Sponsor
First posted
Jun 24, 2025
Start date
Jun 1, 2025
Primary completion
May 30, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Jul 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion